Parts circulation industry problems China's auto production and sales have grown rapidly. In 2012, the number of civilian vehicles reached 110 million, driving the rapid development of the entire industrial chain of auto parts production, sales, maintenance and maintenance. The scale of the industry has continued to expand. However, the development of the circulation system , the protection of policies and regulations, and the regulation and supervision of the market are still incomplete. Many outstanding issues need to be solved, mainly in the following aspects: First, the current classification of accessories is not conducive to industry competition and management. The definition of "original parts" and "deputy parts" in China is defined based on the distribution channels of the parts. The so-called "original parts" refers to the parts that are included in the after-sales service of the vehicle manufacturer and the parts supply system. The parts and components that are produced by the same parts supplier according to the same specifications are considered to be “deputy parts†when they are sold through their own distribution system, which easily leads to distrust of the consumers, is not conducive to fair competition, and disguisedly results in auto parts suppliers’ monopoly. . The second is that auto suppliers control the distribution channels of original parts, and 4S stores are expensive to repair and maintain. The auto supplier strictly forbids parts suppliers and authorized dealers from selling accessories externally and firmly controls the original parts. The 4S store bundles the accessories with the maintenance, resulting in consumers who can only accept high-priced services in the 4S shop, and their rights and interests are damaged. Under normal circumstances, the original accessories from the vehicle manufacturer to authorized dealers to increase the price by more than 50%, dealers to increase the price after the sale to the user, through layers of price increases, the original parts of the price will turn several times or even more than ten times. The problem of high prices of imported car original parts is even more prominent. This is also the main reason why most consumers choose to go to an independent repair shop for maintenance after passing the vehicle warranty period. Third, the quality of channel accessories such as Auto Parts City is uneven, bringing serious security risks. The closure of original accessories circulation channels further exacerbated the circulation of counterfeit parts in the market. Auto Parts City and some small accessories retailers are flooded with a large number of imitation, poor quality auto parts, the average consumer is difficult to identify, the use of such accessories for consumers to travel significant security risks. Fourth, parts circulation is too long, circulation costs are high, and large distribution groups are lacking. The small-scale dealers complement each other and raise prices at various levels, pushing up the circulation costs, and the development of large-scale dealers adopting such modes as chain operations and e-commerce lags behind. Fifth, independent maintenance companies cannot obtain accessories and maintenance technical information and cannot compete fairly with authorized maintenance companies. The experience of developed countries in building an efficient auto parts distribution system is worth learning The EU's accessories distribution system is complete and competitive. The first is the formation of an auto supplier authorized accessory distribution system and an independent distribution system, both of which account for half of the market share. Second, there is a clear trend in the conglomeration of EU accessory distributors. Currently there are about 23,000 independent distributors in the European Union (excluding specialized distributors such as tires, glass, and coatings), of which only 0.7% have annual sales of over 20 million Euros, but they have sold 59% of the entire channel. Accessories. Major distributors include Skober, SAG, TROST, KGK and others. Thirdly, modern methods such as the EU parts e-commerce platform (B2B, B2C), modern logistics technology, and supply chain management have been well applied in the auto parts distribution field, and they have continuously created new business models and improved the level of business development. The EU's auto industry exemption regulations and related guidelines and instructions have played an important role in regulating the circulation of accessories and the development of the maintenance industry. First, according to the accessories' product quality and technical standards, the accessories are divided into original parts and quality equivalent parts; second, auto suppliers cannot limit their parts suppliers to sell parts to independent aftermarket; third, they can't limit authorized maintenance companies from The independent after-sales market receives original parts or quality equivalent parts for auto repair and maintenance services. Fourth, it is not allowed to authorize authorized dealers and maintenance companies to sell spare parts to independent maintenance companies for auto repair and maintenance services. Fifth, it is not possible to limit the supply of spare parts. Businesses use their own trademarks and logos on supplied accessories. Sixthly, automakers must fairly disclose vehicle maintenance information to authorized repairers and independent repairers.
Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid.
Empagliflozin is a C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It has a role as a sodium-glucose transport protein subtype 2 inhibitor and a hypoglycemic agent. It is a C-glycosyl compound, an aromatic ether, a tetrahydrofuryl ether and a member of monochlorobenzenes. Empagliflozin; 864070-44-0; JARDIANCE; BI 10773; Empagliflozin (BI 10773); Â Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com
The problem highlights the need for automation of vehicle maintenance parts circulation system